These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5843362)

  • 1. [Myasthenic syndrome as a rare complication of hydantoin treatment].
    Regli F; Guggenheim P
    Nervenarzt; 1965 Jul; 36(7):315-8. PubMed ID: 5843362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myasthenic syndrome following long-term diphenylhydantoin therapy].
    Milonas J; Kountouris D; Scheer E
    Nervenarzt; 1983 Aug; 54(8):437-8. PubMed ID: 6413870
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies in myasthenia gravis: use of edrophonium chloride (Tensilon) in differentiating myasthenic from cholinergic weakness.
    OSSERMAN KE; KAPLAN LI
    AMA Arch Neurol Psychiatry; 1953 Sep; 70(3):385-92. PubMed ID: 13079360
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myasthenic syndrome. Diagnostic trends].
    Gajdos P
    Rev Prat; 2000 Feb; 50(4):419-23. PubMed ID: 10748676
    [No Abstract]   [Full Text] [Related]  

  • 5. [Simultaneous occurrence of myasthenia gravis, epilepsy and struma in childhood].
    Mortier W; Schenk K; Kleu G
    Nervenarzt; 1971 Sep; 42(9):498-501. PubMed ID: 4999164
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant lymphoma following years of hydantoin treatment for epilepsy].
    Jungi WF; Senn HJ; Stanisic M; Rösli R
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1735-7. PubMed ID: 1215968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis associated with diphenylhydantoin therapy for epilepsy.
    Brumlik J; Jacobs RS
    Can J Neurol Sci; 1974 May; 1(2):127-9. PubMed ID: 4215556
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of diagnostic tests in myasthenia gravis.
    Nicholson GA; McLeod JG; Griffiths LR
    Clin Exp Neurol; 1983; 19():45-9. PubMed ID: 6568927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological abnormalities and hydantoins.
    Grob PJ; Herold GE
    Br Med J; 1972 Jun; 2(5813):561-3. PubMed ID: 5032783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complications in the central nervous system in the treatment of epileptics with hydantoins (author's transl)].
    Gottwald W
    MMW Munch Med Wochenschr; 1975 Dec; 117(51-52):2005-10. PubMed ID: 818510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hydantoin fetal syndrome].
    Dang PM; Dufetelle B; Bonnetblanc JM
    Ann Dermatol Venereol; 1993; 120(9):621-4. PubMed ID: 8161117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution to the question of hypertrophic gingivitis caused by hydantoin therapy of cerebral seizures in childhood and youth].
    Kluge D; Schnell H
    Stoma (Heidelb); 1966 May; 19(2):90-5. PubMed ID: 5221039
    [No Abstract]   [Full Text] [Related]  

  • 13. The neuromuscular junction. Part II: myasthenia gravis.
    Brumback RA
    Am Fam Physician; 1981 Feb; 23(2):126-33. PubMed ID: 7457320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of myasthenia gravis associated with long-term phenytoin therapy].
    Ozawa T; Nakajima T; Furui E; Fukuhara N
    Rinsho Shinkeigaku; 1996 Nov; 36(11):1262-4. PubMed ID: 9046861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Letter: Leukemia following treatment with hydantoin].
    Endtz LJ; Leeksma CH; Kerkhofs H; Mulder OG; Mosmans FA; Meinardi H
    Munch Med Wochenschr; 1973 Oct; 115(42):1859. PubMed ID: 4520458
    [No Abstract]   [Full Text] [Related]  

  • 16. Coexistence of epilepsy, myasthenia gravis and psoriasis vulgaris.
    Kwan SY; Lin JH; Su MS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):153-7. PubMed ID: 10677928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tensilon in myasthenia gravis.
    WESTERBERG MR; MAGEE KR; SHIDEMAN FE
    Neurology; 1953 Apr; 3(4):302-5. PubMed ID: 13054858
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hydantoin derivatives and malignancies of the haemopoietic system].
    Bichel J
    Folia Clin Int (Barc); 1976 Oct; 26(10):420-1. PubMed ID: 1036724
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sperm analysis of patients after long term use of hydantoin].
    Schramm P; Seyfeddinipur N
    Andrologia; 1980; 12(1):97-101. PubMed ID: 6769360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphadenopathy resulting from long-term use of hydantoin.
    Szegedi G; Krasznai G; Sorszegi P; Szabó G
    Acta Med Acad Sci Hung; 1970; 27(3):243-51. PubMed ID: 5511166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.